Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 30531916 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| beneficial role of cd8+ t-cell reconstitution after hla-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological ebmt registry study mostly in the t-cell-depleted setting. | |||||||
| 30531916 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| hla-haploidentical haematopoietic stem cell transplantation (haplo-hsct) is increasingly offered to patients with high-risk acute leukaemia. | |||||||
| 30814997 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | NA | NA | NA | positive | |
| hemophagocytic lymphohistiocytosis (hlh) has recently been increasingly reported as an important complication after stem cell transplantation, in line with the increase in the number of hla-mismatched transplantation. | |||||||
| 30814997 | HLA MISMATCHED (HLA-MISMATCHED) | hemophagocytic lymphohistiocytosis | NA | NA | NA | positive | |
| hemophagocytic lymphohistiocytosis (hlh) has recently been increasingly reported as an important complication after stem cell transplantation, in line with the increase in the number of hla-mismatched transplantation. | |||||||
| 30820933 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| we compared the outcome of 4214 saml patients who received allogeneic haematopoietic stem cell transplantation (allo-hsct) from an unrelated (62%) or human leucocyte antigen (hla)-identical sibling donor (38%) according the underlying disease: mds (n = 3541), cmml (n = 251) or mpn (n = 422). | |||||||
| 30826463 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| donor-specific anti-hla antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes. | |||||||
| 30826463 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | positive | |
| the presence of donor-specific anti-hla antibodies (dsa) is associated with a 10-fold increased risk of graft failure in haploidentical stem cell transplantation (haplo-sct). | |||||||
| 30875143 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | methylprednisolone | NA | unclassified | |
| human leukocyte antigen (hla) mismatch and the administration of immunosuppressive agents are considered risks for human herpesvirus 6 (hhv-6) reactivation after stem cell transplantation (sct). | |||||||
| 31104211 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| hla-haploidentical stem cell transplantation using posttransplant cyclophosphamide. | |||||||
| 31104211 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| hla-haploidentical stem cell transplantation using posttransplant cyclophosphamide has spread rapidly worldwide. | |||||||
Copyright 2024